{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:02:12Z","timestamp":1785769332948,"version":"3.56.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-06151-1","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T21:41:29Z","timestamp":1751406089000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comparison of two transient elastography (TE) systems for measuring liver stiffness in clinical practice"],"prefix":"10.1038","volume":"15","author":[{"given":"Simone","family":"Cappelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Salvati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Petralli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"De Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Ricco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Colombatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Coco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Oliveri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Faita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferruccio","family":"Bonino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizia Rossana","family":"Brunetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"3","key":"6151_CR1","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","volume":"75","author":"A Berzigotti","year":"2021","unstructured":"Berzigotti, A. et al. EASL clinical practice guidelines on non-invasive tests for evaluation of liver disease severity and prognosis \u2013 2021 update. J. Hepatol. 75 (3), 659\u2013689 (2021).","journal-title":"J. Hepatol."},{"issue":"1","key":"6151_CR2","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1053\/j.gastro.2008.03.076","volume":"135","author":"L Huwart","year":"2008","unstructured":"Huwart, L. et al. Magnetic resonance elastography for the noninvasive staging of liver fibrosis. Gastroenterology 135 (1), 32\u201340 (2008).","journal-title":"Gastroenterology"},{"issue":"1","key":"6151_CR3","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jhep.2015.04.006","volume":"63","author":"L Castera","year":"2015","unstructured":"Castera, L. et al. EASL-ALEH clinical practice guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. J. Hepatol. 63 (1), 237\u2013264 (2015).","journal-title":"J. Hepatol."},{"key":"6151_CR4","doi-asserted-by":"crossref","unstructured":"Brattain, LJ. et al. Objective Liver Fibrosis Estimation from Shear Wave Elastography. Annu Int Conf IEEE Eng Med Biol Soc. 2018 Jul;2018:1-5.","DOI":"10.1109\/EMBC.2018.8513011"},{"key":"6151_CR5","doi-asserted-by":"crossref","unstructured":"Castera L, Forns X, Alberti A. Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol. 2008 May;48(5):835-47.","DOI":"10.1016\/j.jhep.2008.02.008"},{"issue":"12","key":"6151_CR6","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.cgh.2013.07.034","volume":"11","author":"S Singh","year":"2013","unstructured":"Singh, S. et al. Liver stiffness is associated with risk of decompensation, liver cancer, and death in patients with chronic liver diseases: a systematic review and meta-analysis. Clin. Gastroenterol. Hepatol. [Internet]. 11 (12), 1573\u20131584e2 (2013). [cited 2024 Feb 12];.","journal-title":"Clin. Gastroenterol. Hepatol. [Internet]"},{"key":"6151_CR7","doi-asserted-by":"crossref","unstructured":"Vilar-Gomez, E., Vuppalanchi, R., Gawrieh, S., Samala, N. & Chalasani, N. CAP and LSM as determined by VCTE are independent predictors of all-cause mortality in the US adult population. Hepatology [Internet]. Apr 1 [cited 2024 Feb 12];77(4):1241\u201352. (2023).","DOI":"10.1097\/HEP.0000000000000023"},{"issue":"8","key":"6151_CR8","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/S2468-1253(23)00141-3","volume":"8","author":"FE M\u00f3zes","year":"2023","unstructured":"M\u00f3zes, F. E. et al. Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis. Lancet Gastroenterol. Hepatol. 8 (8), 704\u2013713 (2023).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"6151_CR9","doi-asserted-by":"crossref","unstructured":"de Franchis, R. et al. Baveno VII - Renewing consensus in portal hypertension. J Hepatol. Apr 1 [cited 2024 Feb 12];76(4):959\u201374. (2022).","DOI":"10.1007\/978-3-031-08552-9"},{"issue":"5","key":"6151_CR10","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/j.1365-2893.2006.00811.x","volume":"14","author":"B Coco","year":"2007","unstructured":"Coco, B. et al. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J. Viral Hepat. 14 (5), 360\u2013369 (2007).","journal-title":"J. Viral Hepat."},{"issue":"3","key":"6151_CR11","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.amjcard.2013.10.018","volume":"113","author":"T Taniguchi","year":"2014","unstructured":"Taniguchi, T. et al. Usefulness of transient elastography for noninvasive and reliable Estimation of Right-Sided filling pressure in heart failure. Am. J. Cardiol. 113 (3), 552\u2013558 (2014).","journal-title":"Am. J. Cardiol."},{"issue":"5","key":"6151_CR12","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.jhep.2008.02.008","volume":"48","author":"L Castera","year":"2008","unstructured":"Castera, L., Forns, X. & Alberti, A. Non-invasive evaluation of liver fibrosis using transient elastography. J. Hepatol. 48 (5), 835\u2013847 (2008).","journal-title":"J. Hepatol."},{"issue":"2","key":"6151_CR13","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/hep.22056","volume":"47","author":"A Sagir","year":"2008","unstructured":"Sagir, A., Erhardt, A., Schmitt, M. & H\u00e4ussinger, D. Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage. Hepatol. [Internet]. 47 (2), 592\u2013595 (2008).","journal-title":"Hepatol. [Internet]"},{"issue":"2","key":"6151_CR14","doi-asserted-by":"publisher","first-page":"111","DOI":"10.11152\/mu.2013.2066.152.is1ir2","volume":"15","author":"I Sporea","year":"2013","unstructured":"Sporea, I., Ra\u0163iu, I., Bota, S., \u015eirli, R. & Jurchi\u015f, A. Are different cut-off values of liver stiffness assessed by transient elastography according to the etiology of liver cirrhosis for predicting significant esophageal varices? Med. Ultrason. [Internet]. 15 (2), 111\u2013115 (2013).","journal-title":"Med. Ultrason. [Internet]"},{"issue":"6","key":"6151_CR15","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/j.jhep.2022.07.016","volume":"77","author":"E Degasperi","year":"2022","unstructured":"Degasperi, E. et al. Bulevirtide monotherapy for 48 weeks in patients with HDV-related compensated cirrhosis and clinically significant portal hypertension. J. Hepatol. [Internet]. 77 (6), 1525\u20131531 (2022).","journal-title":"J. Hepatol. [Internet]"},{"issue":"6","key":"6151_CR16","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1111\/liv.13623","volume":"38","author":"S Wu","year":"2018","unstructured":"Wu, S. et al. On-treatment changes of liver stiffness at week 26 could predict 2-year clinical outcomes in HBV-related compensated cirrhosis. Liver Int. 38 (6), 1045\u20131054 (2018).","journal-title":"Liver Int."},{"issue":"4","key":"6151_CR17","doi-asserted-by":"publisher","first-page":"E00323","DOI":"10.14309\/ctg.0000000000000323","volume":"12","author":"Y Qu","year":"2021","unstructured":"Qu, Y. et al. Diagnostic performance of fibrotouch ultrasound Attenuation parameter and liver stiffness measurement in assessing hepatic steatosis and fibrosis in patients with nonalcoholic fatty liver disease. Clin. Transl Gastroenterol. [Internet]. 12 (4), E00323 (2021).","journal-title":"Clin. Transl Gastroenterol. [Internet]"},{"issue":"4","key":"6151_CR18","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1002\/hep.29639","volume":"67","author":"C Caussy","year":"2018","unstructured":"Caussy, C. et al. Optimal threshold of controlled Attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis. Hepatology 67 (4), 1348\u20131359 (2018).","journal-title":"Hepatology"},{"issue":"9","key":"6151_CR19","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.dld.2019.02.009","volume":"51","author":"Y Xu","year":"2019","unstructured":"Xu, Y. et al. Comparison of fibrotouch and fibroscan for staging fibrosis in chronic liver disease: Single-center prospective study. Dig. Liver Dis. 51 (9), 1323\u20131329 (2019).","journal-title":"Dig. Liver Dis."},{"issue":"2","key":"6151_CR20","first-page":"103","volume":"23","author":"X Ou","year":"2015","unstructured":"Ou, X. et al. [Comparison of fibrotouch and fibroscan for the assessment of fibrosis in chronic hepatitis B patients]. Zhonghua Gan Zang Bing Za Zhi. 23 (2), 103\u2013106 (2015).","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"2","key":"6151_CR21","first-page":"145","volume":"25","author":"GF Chen","year":"2017","unstructured":"Chen, G. F. et al. [Correlation of liver stiffness measured by fibrotouch and fibroscan with Ishak fibrosis score in patients with chronic hepatitis B]. Zhonghua Gan Zang Bing Za Zhi. 25 (2), 145\u2013150 (2017).","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"9","key":"6151_CR22","first-page":"652","volume":"24","author":"J Zeng","year":"2016","unstructured":"Zeng, J. et al. [Efficiency of fibroscan and fibrotouch in liver stiffness measurement and fat quantification: a comparative analysis]. Zhonghua Gan Zang Bing Za Zhi. 24 (9), 652\u2013658 (2016).","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"4","key":"6151_CR23","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.jhep.2011.10.017","volume":"56","author":"V de L\u00e9dinghen","year":"2012","unstructured":"de L\u00e9dinghen, V. et al. Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: comparison between M and XL probe of FibroScan\u00ae. J. Hepatol. 56 (4), 833\u2013839 (2012).","journal-title":"J. Hepatol."},{"issue":"5","key":"6151_CR24","doi-asserted-by":"publisher","first-page":"e0250300","DOI":"10.1371\/journal.pone.0250300","volume":"16","author":"YZ Ng","year":"2021","unstructured":"Ng, Y. Z. et al. Attenuation parameter and liver stiffness measurement using fibrotouch vs fibroscan in patients with chronic liver disease. PLoS One. 16 (5), e0250300 (2021).","journal-title":"PLoS One"},{"key":"6151_CR25","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2147\/HMER.S245455","volume":"12","author":"JT Serra","year":"2020","unstructured":"Serra, J. T., Mueller, J., Teng, H., Elshaarawy, O. & Mueller, S. Prospective comparison of transient elastography using two different devices: performance of fibroscan and fibrotouch. Hepat. Med. 12 41\u201348 (2020).","journal-title":"Hepat. Med."},{"issue":"3","key":"6151_CR26","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","volume":"81","author":"F Tacke","year":"2024","unstructured":"Tacke, F. et al. EASL\u2013EASD\u2013EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J. Hepatol. [Internet]. 81 (3), 492\u2013542 (2024).","journal-title":"J. Hepatol. [Internet]"},{"key":"6151_CR27","doi-asserted-by":"crossref","unstructured":"Ajmera, V. et al. A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes. J Hepatol. 2023 Mar;78(3):471-478.","DOI":"10.1016\/j.jhep.2022.11.010"},{"issue":"8","key":"6151_CR28","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/S2468-1253(23)00017-1","volume":"8","author":"Y Vali","year":"2023","unstructured":"Vali, Y. et al. Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy study. Lancet Gastroenterol. Hepatol. 8 (8), 714\u2013725 (2023).","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"4","key":"6151_CR29","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1053\/j.gastro.2023.05.053","volume":"165","author":"S Man","year":"2023","unstructured":"Man S, Deng Y, Ma Y, Fu J, Bao H, Yu C, et al Prevalence of liver steatosis and fibrosis in the general population and various High-Risk populations: A nationwide study with 5.7 million adults in China.Gastroenterology [Internet]. 2023; 165((4),):1025\u201340.","journal-title":"Gastroenterology [Internet]"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06151-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06151-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06151-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T21:41:33Z","timestamp":1751406093000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06151-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6151"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-06151-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"21 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Informed consent was obtained from all individual participants included in the study. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. MRB: advisory board for Gilead Sciences and Roche; speaker for AbbVie, Gilead, AstraZeneca and EISAI-MSD. PC: advisory board for Abbvie and Ipsen; speaker for Gilead Sciences and Abbvie.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and informed consent"}}],"article-number":"22277"}}